BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2025 9:02:12 AM | Browse: 88 | Download: 85
 |
Received |
|
2025-05-28 08:59 |
|
Peer-Review Started |
|
2025-05-28 08:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-06-17 02:49 |
|
Revised |
|
2025-06-30 15:46 |
|
Second Decision |
|
2025-08-06 02:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-08-06 04:34 |
|
Articles in Press |
|
2025-08-06 04:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-11 02:31 |
|
Publish the Manuscript Online |
|
2025-09-24 09:02 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Radiology, Nuclear Medicine & Medical Imaging |
| Manuscript Type |
Retrospective Study |
| Article Title |
Diagnostic significance of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating Edmondson grade II and III hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-Bo Niu, Yan-Peng Li, Fang-Fang Chao, Xiao-Li Mei, Xing-Min Han and Rui-Hua Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82171983 |
| Henan Provincial Science and Technology Research Project |
242102311089 |
|
| Corresponding Author |
Rui-Hua Wang, DM, Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou 450052, Henan Province, China. wangruihua2004@126.com |
| Key Words |
Hepatocellular carcinoma; Fluorine-18-fluorodeoxyglucose; Positron emission tomography-computed tomography; Metabolic parameters; Edmondson grading |
| Core Tip |
Fluorine-18-fluorodeoxyglucose (18F-FDG)-positron emission tomography/computed tomography technology has established its indispensable position in numerous aspects of liver cancer diagnosis, staging, lymph node metastasis assessment, and prognosis prediction. The hypermetabolic nature of malignant cells, induced by accelerated glycolysis, increases 18F-FDG uptake. Results have revealed an intimate connection between 18F-FDG uptake and hepatocellular carcinoma differentiation status. This study assessed the diagnostic potential of conventional and three-dimensional metabolic 18F-FDG-positron emission tomography/computed tomography parameters in differentiating Edmondson grade II from grade III hepatocellular carcinoma. |
| Publish Date |
2025-09-24 09:02 |
| Citation |
<p>Niu XB, Li YP, Chao FF, Mei XL, Han XM, Wang RH. Diagnostic significance of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating Edmondson grade II and III hepatocellular carcinoma. <i>World J Gastrointest Surg</i> 2025; 17(9): 107301</p> |
| URL |
https://www.wjgnet.com/1948-9366/full/v17/i9/107301.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v17.i9.107301 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
